BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 35664963)

  • 21. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer.
    Kim N; Gim JA; Lee BJ; Choi BI; Yoon HS; Kim SH; Joo MK; Park JJ; Kim C
    Sci Rep; 2022 Aug; 12(1):13447. PubMed ID: 35927305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated microbiota in colorectal cancer with vascular tumor thrombus and neural invasion and association with clinical prognosis.
    Li M; Jin M; Zhao L; Yu D; Li Y; Shi L; Zhou B; Liu L; Cao Y; Cai K; Fan J; Nie X; Zhang T; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):366-378. PubMed ID: 37905339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.
    Yang TW; Lee WH; Tu SJ; Huang WC; Chen HM; Sun TH; Tsai MC; Wang CC; Chen HY; Huang CC; Shiu BH; Yang TL; Huang HT; Chou YP; Chou CH; Huang YR; Sun YR; Liang C; Lin FM; Ho SY; Chen WL; Yang SF; Ueng KC; Huang HD; Huang CN; Jong YJ; Lin CC
    Sci Rep; 2019 Jul; 9(1):10923. PubMed ID: 31358825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences.
    Berbert L; Santos A; Magro DO; Guadagnini D; Assalin HB; Lourenço LH; Martinez CAR; Saad MJA; Coy CSR
    Braz J Med Biol Res; 2022; 55():e11832. PubMed ID: 35293551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota in patients after surgical treatment for colorectal cancer.
    Jin Y; Liu Y; Zhao L; Zhao F; Feng J; Li S; Chen H; Sun J; Zhu B; Geng R; Wei Y
    Environ Microbiol; 2019 Feb; 21(2):772-783. PubMed ID: 30548192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidating colorectal cancer-associated bacteria through profiling of minimally perturbed tissue-associated microbiota.
    Fukuoka H; Tourlousse DM; Ohashi A; Suzuki S; Nakagawa K; Ozawa M; Ishibe A; Endo I; Sekiguchi Y
    Front Cell Infect Microbiol; 2023; 13():1216024. PubMed ID: 37593761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.
    Lin C; Li B; Tu C; Chen X; Guo M
    Biomed Res Int; 2022; 2022():3140070. PubMed ID: 35937408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
    Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
    mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
    Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
    World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 37. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
    Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
    Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.